Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 9, Pages e1326442
Publisher
Informa UK Limited
Online
2017-06-08
DOI
10.1080/2162402x.2017.1326442
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- The Human Vaccines Project: A roadmap for cancer vaccine development
- (2016) Pedro Romero et al. Science Translational Medicine
- Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
- (2015) Stephanie Downs-Canner et al. ANNALS OF SURGICAL ONCOLOGY
- PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
- (2015) Eduardo Bonavita et al. CELL
- Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma
- (2015) Marta Mazzocco et al. IMMUNOLOGY
- Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration
- (2015) Chunmei Piao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Monitoring and Cell-Specific Deletion of C5aR1 Using a Novel Floxed GFP-C5aR1 Reporter Knock-in Mouse
- (2015) Christian M. Karsten et al. JOURNAL OF IMMUNOLOGY
- A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma
- (2015) Stefano Pierini et al. JOURNAL OF IMMUNOLOGY
- Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization
- (2015) Selene Nunez-Cruz et al. NEOPLASIA
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature
- (2014) John G. Facciponte et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells
- (2014) S. B. J. Wong et al. JOURNAL OF IMMUNOLOGY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Autocrine Effects of Tumor-Derived Complement
- (2014) Min Soon Cho et al. Cell Reports
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Alloantibody and Complement Promote T Cell–Mediated Cardiac Allograft Vasculopathy Through Noncanonical Nuclear Factor-κB Signaling in Endothelial Cells
- (2013) Dan Jane-wit et al. CIRCULATION
- Deciphering and Reversing Tumor Immune Suppression
- (2013) Greg T. Motz et al. IMMUNITY
- An Essential Role for C5aR Signaling in the Optimal Induction of a Malaria-Specific CD4+ T Cell Response by a Whole-Killed Blood-Stage Vaccine
- (2013) T. Liu et al. JOURNAL OF IMMUNOLOGY
- Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
- (2013) D. Ricklin et al. JOURNAL OF IMMUNOLOGY
- New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties
- (2012) Hongchang Qu et al. IMMUNOBIOLOGY
- C5aR Expression in a Novel GFP Reporter Gene Knockin Mouse: Implications for the Mechanism of Action of C5aR Signaling in T Cell Immunity
- (2012) J. Dunkelberger et al. JOURNAL OF IMMUNOLOGY
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Cyclic GMP protects endothelial progenitors from oxidative stress
- (2011) Anna Maria Curatola et al. ANGIOGENESIS
- Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes
- (2011) A. Palazon et al. CANCER RESEARCH
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
- (2010) R. Bos et al. CANCER RESEARCH
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Endothelin B Receptor, a New Target in Cancer Immune Therapy
- (2009) L. E. Kandalaft et al. CLINICAL CANCER RESEARCH
- Self-antigen–specific CD8+T cell precursor frequency determines the quality of the antitumor immune response
- (2009) Gabrielle A. Rizzuto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis
- (2009) Theresa N. Ramos et al. NEUROSCIENCE LETTERS
- Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis
- (2008) P. N. Lalli et al. BLOOD
- Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer
- (2008) C. Mennuni et al. CANCER RESEARCH
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells
- (2008) Michael G. Strainic et al. IMMUNITY
- Cancer exploiting complement: a clue or an exception?
- (2008) Bruce E Loveland et al. NATURE IMMUNOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
- Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen
- (2008) Jian Yan et al. VACCINE
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now